The role of Asprosin in patients with dilated cardiomyopathy

BACKGROUND: Asprosin is a novel fasting glucogenic adipokine discovered in 2016. Asprosin induces rapid glucose releases from the liver. However, its molecular mechanisms and function are still unclear. Adaptation of energy substrates from fatty acid to glucose is recently considered a novel therape...

Descripción completa

Detalles Bibliográficos
Autores principales: Wen, Ming-Shien, Wang, Chao-Yung, Yeh, Jih-Kai, Chen, Chun-Chi, Tsai, Ming-Lung, Ho, Ming-Yun, Hung, Kuo-Chun, Hsieh, I-Chang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7487662/
https://www.ncbi.nlm.nih.gov/pubmed/32894050
http://dx.doi.org/10.1186/s12872-020-01680-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7487662/
https://www.ncbi.nlm.nih.gov/pubmed/32894050
http://dx.doi.org/10.1186/s12872-020-01680-1

Ejemplares similares